Advanced Search

Journal of Traditional Chinese Medicine ›› 2021, Vol. 41 ›› Issue (4): 650-656.DOI: 10.19852/j.cnki.jtcm.2021.04.015

Previous Articles    

Traditional Chinese Medicine reverses resistance to epidermal growth factor receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer: a narrative review

CHEN Jiayang, FENG Li   

  1. Department of Traditional Chinese Medicine,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College;
  • Online:2021-08-06 Published:2021-02-03
  • Supported by:
    Supported by Capital Health Development Research Project:Analysis of the Characteristics of Advanced Gastrointestinal Cancer Survivors Who Benefitted from Traditional Chinese Medicine (TCM) Treatment based on a Real-world Registry Study (No. 2016-1-4171), Capital's Funds For Health Improvement and Research (2020-2-4026):A Multicenter Clinical Study of Yishengukang Prescription with the function of Invigorating,Detoxifying and Removing blood stasis for the Treatment of Cancer Body Pain based on the Drugability Analysis, Peking Union Medical College Academic Construction Projects(201920100302):Integrating Chinese and Modern Medicine in Oncology

PDF

1057

Abstract: OBJECTIVE: To review mechanisms of the resistance to epidermal growth factor receptor tyrosine kinase inhibitors(EGFR-TKIs) in the treatment of non-small cell lung cancer and the reversal of this resistance by traditional Chinese herbal medicines(CHMs).METHODS: Searching China National Knowledge Infrastructure Database, Wanfang Database, China Science and Technology Journal Database, Pub Med and Embase for related researches.RESULTS: T790 M mutation, MET amplification,C797 S mutation, Inactivation of PTEN gene expression and Epithelial-mesenchymal transition(EMT)are the main mechanisms of the resistance to EGFR-TKIs. CHMs may reverse the resistance by inhibiting MET activation, inhibiting PI3K/AKT pathways,regulating apoptosis and P-glycoprotein(P-gp).CONCLUSION: Many resistance mechanisms of EGFR-TKIs in the treatment of non-small cell lung cancer still need to be explored. CHMs have great research potential in reversing the resistance to EGFR-TKIs.

Key words: carcinoma,non-small-cell lung, ErbB receptors, drug resistance, herbal medicine

Cite this article

CHEN Jiayang, FENG Li. Traditional Chinese Medicine reverses resistance to epidermal growth factor receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer: a narrative review[J]. Journal of Traditional Chinese Medicine, 2021, 41(4): 650-656.